Behavioral Health Market Share

  • Report ID: 4441
  • Published Date: Jun 10, 2025
  • Report Format: PDF, PPT

Behavioral Health Industry - Regional Synopsis

North America Market Analysis

The North America behavioral health market is projected to account for the largest share of 42.6%, further rising at a CAGR of 6.3% during the forecast timeline. The dominance of the region is effectively attributed to the U.S. holding 88.5% of regional market share, owing to the expanded Medicare and Medicaid expenditures. Besides Canada market grows at 5.8% CAGR with the presence of provincial healthcare funding. Simultaneously telehealth adoption will positively contribute to 43% of the U.S. therapy professionals offering services by 2030, thus positioning North America as a key leader in the sector.

The behavioral health market in the U.S. is exceptionally dominant in the overall region, which is projected to reach USD 425 billion by the end of 2037.  The country benefits from federal healthcare spending that is USD 5.5 billion in 2023 and Medicare expansion with USD 850 million in 2024. Besides, there is a surge in terms of telehealth claims with 3505 after the pandemic outbreak. Also, the country constitutes the Bipartisan Safer Communities Act that extends its reinforcement for school and crisis care, thus boosting business in the sector.

The Canada behavioral health market is gaining immense exposure facilitated by the enhanced healthcare expenditures by Ontario. The market is expected to reach USD 58.8 billion by the assessed timeframe, with Ontario dominating by 20% increased spending from 2021 to 2024, thus benefiting over 250,000 patients annually. Besides, the federal healthcare funding rose by USD 3.3 billion, which is 10% of the healthcare budget. The psychedelic therapy trials are gaining traction with AI-based tools gaining USD 50.4 million in grants, hence denoting a positive market development.

APAC Market Statistics

The Asia Pacific behavioral health market is set to witness the fastest growth, possessing a CAGR of 7.5%, and is expected to reach USD 225.7 billion by the end of the forecast duration. The region benefits from an expanded adoption of digital health and government healthcare initiatives. Besides, the region presents an intensifying landscape with China and India capturing over 50% of the share. In South Korea, 45% of adults report depression, reflecting an increased demand, thus dragging the interest of leaders to invest in the sector.

China's behavioral health market is experiencing continuous upliftment, grabbing a 38.6% of regional share. The dominance of the country is facilitated by the boom in the telehealth sector, with over 500 million cases covered by the national platform. NHC states that 30% of university students intend to seek care, with youth mental health gaining exposure. Besides, in 2023, over 200 public awareness campaigns were conducted that accelerated adoption. Moreover, the investments towards AI, which is USD 1.2 billion, further boost business in the country.

The India behavioral health market is undergoing numerous transformations, with a measurable success recorded attributed to the 18.5% of regional market share. The growth in the country relies on the aspect of healthcare disparities, as 86% of patients lack access, thus boosting demand for affordable generics. Besides, the Mental Healthcare Act imposed in the country facilitates a favorable business environment towards coverage with an expanded consumer base. On the other hand, in 2024, telemedicine users grew by 50 million users on government platforms, which amplifies to market expansion in India.

Behavioral Health Market Share

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of the behavioral health market was over USD 225.8 billion.

The market size for the behavioral health market is projected to reach USD 420.7 billion by the end of 2037, expanding at a CAGR of 6.2% during the forecast period, i.e., between 2025-2037.

The major players in the market are Johnson & Johnson, Pfizer, Eli Lilly, Novartis, Roche, GlaxoSmithKline (GSK), and others.

In terms of the disorder segment, the depression segment is anticipated to garner the largest market share of 32.9% by 2037 and display lucrative growth opportunities during 2025-2037.

The market in North America is projected to hold the largest market share of 42.6% by the end of 2037 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos